Found: 32
Select item for more details and to access through your institution.
Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy.
- Published in:
- BJU International, 2018, v. 122, n. 1, p. 89, doi. 10.1111/bju.14211
- By:
- Publication type:
- Article
Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.
- Published in:
- BJU International, 2017, v. 119, n. 5, p. 684, doi. 10.1111/bju.13689
- By:
- Publication type:
- Article
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.621591
- By:
- Publication type:
- Article
Bladder Cancer: Can We Move Beyond Chemotherapy?
- Published in:
- Current Oncology Reports, 2010, v. 12, n. 4, p. 278, doi. 10.1007/s11912-010-0104-5
- By:
- Publication type:
- Article
Frequent truncating mutations of STAG2 in bladder cancer.
- Published in:
- Nature Genetics, 2013, v. 45, n. 12, p. 1428, doi. 10.1038/ng.2800
- By:
- Publication type:
- Article
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.
- Published in:
- Cancer & Metastasis Reviews, 2009, v. 28, n. 3/4, p. 335, doi. 10.1007/s10555-009-9194-7
- By:
- Publication type:
- Article
EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-05992-x
- By:
- Publication type:
- Article
Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 9, p. 1089, doi. 10.1007/s10147-019-01450-w
- By:
- Publication type:
- Article
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25894-9
- By:
- Publication type:
- Article
Inhibition of Inducible Heat Shock Protein-70 (Hsp72) Enhances Bortezomib-Induced Cell Death in Human Bladder Cancer Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069509
- By:
- Publication type:
- Article
p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0030206
- By:
- Publication type:
- Article
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 840, doi. 10.1002/cncr.33328
- By:
- Publication type:
- Article
Erdafitinib for locally advanced or metastatic urothelial carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 1, p. 95, doi. 10.1007/s00345-018-2486-1
- By:
- Publication type:
- Article
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.
- Published in:
- World Journal of Urology, 2017, v. 35, n. 3, p. 327, doi. 10.1007/s00345-016-1819-1
- By:
- Publication type:
- Article
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29397-z
- By:
- Publication type:
- Article
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 17, p. 2684, doi. 10.1002/cncr.28767
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 12, p. 1794, doi. 10.1002/cncr.28655
- By:
- Publication type:
- Article
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: A report from the Bladder Cancer Advocacy Network Clinical Trials Working Group
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 11, p. 1994, doi. 10.1002/cncr.27973
- By:
- Publication type:
- Article
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 540, doi. 10.1002/cncr.27751
- By:
- Publication type:
- Article
Incidence of Downstaging and Complete Remission After Neoadjuvant Chemotherapy for High-Risk Upper Tract Transitional Cell Carcinoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 13, p. 3127, doi. 10.1002/cncr.25050
- By:
- Publication type:
- Article
Outcome and Patterns of Recurrence of Nonbilharzial Pure Squamous Cell Carcinoma of the Bladder.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 4, p. 764, doi. 10.1002/cncr.22853
- By:
- Publication type:
- Article
Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 9, p. e2122998, doi. 10.1001/jamanetworkopen.2021.22998
- By:
- Publication type:
- Article
Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma.
- Published in:
- BJUI Compass, 2022, v. 3, n. 1, p. 37, doi. 10.1002/bco2.113
- By:
- Publication type:
- Article
Micropapillary Bladder Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 1, p. 62, doi. 10.1002/cncr.22756
- By:
- Publication type:
- Article
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Pilot trial of bone‐targeted therapy with zoledronate, thalidomide, and interferon‐γ for metastatic renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 3, p. 497
- By:
- Publication type:
- Article